Literature DB >> 16334781

Peripheral lymphocyte subsets vary with stage of hepatitis C virus-associated liver disease.

Kiyoshi Morita1, Yoshihide Fukuda, Isao Nakano, Yoshiaki Katano, Tetsuo Hayakawa.   

Abstract

BACKGROUND/AIMS: Hepatitis C virus induces various clinical features in a host depending on duration of the viral infection.
METHODOLOGY: We investigated peripheral lymphocyte subsets in patients with three different stages of hepatitis C virus infection: 5 patients with acute hepatitis, 10 with chronic hepatitis unassociated with cirrhosis, and 10 with cirrhosis. Peripheral lymphocytes were double-stained with multiple fluorescent antibody combinations: anti-CD3 plus anti-gammasigmaT cell receptor; anti-CD19 plus anti-CD5; anti-CD4 plus anti-CD45RA; or anti-CD8 plus anti-CD11b. Triple staining was performed with fluorescent antibodies against CD4, interferon gamma, and interleukin-4. Both staining protocols were followed by flow cytometric analysis.
RESULTS: Acute hepatitis patients had a high proportion of CD3+ T cells with increased CD4+CD45RA-T helper and CD8+CD11b- cytotoxic T cells. Compared to this group, chronic hepatitis patients showed a decrease in CD4+ cells and an increase in CD19+ B cells and interleukin-4-producing Th2 cells. Cirrhotic patients showed decreased circulating lymphocytes and a low proportion of CD8+ cells accompanied by a decrease in cytotoxic T cells. Furthermore, their lymphocyte profiles showed decreases in primordial lymphocyte subpopulations (T cells with gammasigmaT cell receptors and B cells with CD5).
CONCLUSIONS: Although the same pathogenic agent was involved, immune dynamics differed greatly according to duration of viral infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334781

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Periorbital necrotising fasciitis with underlying undiagnosed hepatitis C infection.

Authors:  Nicholas Cereceda-Monteoliva; Hannah Lewis; Sarah Al-Himdani; Christopher Stone
Journal:  BMJ Case Rep       Date:  2019-04-23

Review 2.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

3.  COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis.

Authors:  Kumar Jayant; Isabella Reccia; Francesco Virdis; Jordan S Pyda; Piotr J Bachul; Diego di Sabato; Rolf N Barth; John Fung; Talia Baker; Piotr Witkowski
Journal:  Clin Transplant       Date:  2021-02-25       Impact factor: 3.456

Review 4.  Mesenchymal stem cell therapy for liver fibrosis/cirrhosis.

Authors:  Yan Cao; Chenbo Ji; Ling Lu
Journal:  Ann Transl Med       Date:  2020-04

5.  B cells were related to HBsAg seroconversion in inactive HBsAg carriers following peginterferon therapy.

Authors:  Zhenhuan Cao; Sha Meng; Yanhong Zheng; Junli Wang; Rui Wang; Xinyue Chen
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

Review 6.  Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.

Authors:  Ann W N Auma; Carey L Shive; Lenche Kostadinova; Donald D Anthony
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.